Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
J Alzheimers Dis ; 86(1): 191-204, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35034906

RESUMEN

BACKGROUND: Alzheimer's disease (AD) characterized by neurofibrillary tangles caused by hyperphosphorylated tau is the most common cause of dementia. Zeaxanthin (Zea), derived from fruits and vegetables, may reduce the risk of AD. Endoplasmic reticulum stress (ERS) might cause memory impairment in AD. OBJECTIVE: Here, we studied protective role of Zea on the relationship among ERS, activity of glycogen synthase kinase 3ß (GSK-3ß, tau phosphorylated kinase), and p-Tau (Ser 396 and Thr 231). METHODS: The results were obtained in non-RA and RA group by using different treatment, such as 9-cis-retinoic acid (RA), TM (ERS inducer), Zea, 4-PBA (ERS inhibitor), and SB216763 (GSK-3ß inhibitor). The methods included flow cytometry and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] for the detections of cell cycle and cell viability and western blot as a third measure of proteins in relation to ERS and tau phosphorylation. We have collected and analyzed all the data that suggested application of drugs for the treatment in non-RA and RA group. RESULTS: Zea displays its protection on TM-induced cell injury, upregulation of GRP78 expression, and change of GSK-3ß activity and tau phosphorylation when 4-PBA and SB216763 interfere with the process. CONCLUSION: These studies indicated that Zea is in vicious circle in ERS, GSK-3ß, and tau phosphorylation, and further reflect its potential value in AD.


Asunto(s)
Estrés del Retículo Endoplásmico , Estrés del Retículo Endoplásmico/fisiología , Glucógeno Sintasa Quinasa 3 beta/metabolismo , Humanos , Fosforilación , Zeaxantinas , Proteínas tau/metabolismo
2.
J Alzheimers Dis ; 77(1): 15-31, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32804091

RESUMEN

The ɛ4 allele of the Apolipoprotein E (APOE) gene in individuals infected by Herpes simplex virus type 1 (HSV-1) has been demonstrated to be a risk factor in Alzheimer's disease (AD). APOE-ɛ4 reduces the levels of neuronal cholesterol, interferes with the transportation of cholesterol, impairs repair of synapses, decreases the clearance of neurotoxic peptide amyloid-ß (Aß), and promotes the deposition of amyloid plaque, and eventually may cause development of AD. HSV-1 enters host cells and can infect the olfactory system, trigeminal ganglia, entorhinal cortex, and hippocampus, and may cause AD-like pathological changes. The lifecycle of HSV-1 goes through a long latent phase. HSV-1 induces neurotropic cytokine expression with pro-inflammatory action and inhibits antiviral cytokine production in AD. It should be noted that interferons display antiviral activity in HSV-1-infected AD patients. Reactivated HSV-1 is associated with infectious burden in cognitive decline and AD. Finally, HSV-1 DNA has been confirmed as present in human brains and is associated with APOEɛ4 in AD. HSV-1 and APOEɛ4 increase the risk of AD and relate to abnormal autophagy, higher concentrations of HSV-1 DNA in AD, and formation of Aß plaques and neurofibrillary tangles.


Asunto(s)
Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/virología , Apolipoproteína E4/genética , Genotipo , Herpesvirus Humano 1/genética , Enfermedad de Alzheimer/metabolismo , Apolipoproteína E4/metabolismo , Encéfalo/metabolismo , Femenino , Herpesvirus Humano 1/metabolismo , Humanos , Masculino
3.
J Alzheimers Dis ; 57(4): 1157-1170, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28339396

RESUMEN

Alzheimer's disease (AD) is a dementia disease with neuronal loss and synaptic impairment. This impairment is caused, at least partly, by the generation of two main AD hallmarks, namely the hyperphosphorylated tau protein comprising neurofibrillary tangles and senile plaques containing amyloid-ß (Aß) peptides. The amyloid-ß protein precursor (AßPP) and glycogen synthase kinase-3ß (GSK3ß) are two main proteins associated with AD and are closely correlated with these hallmarks. Recently, both of the proteins were reported to be modulated by endoplasmic reticulum stress (ERS) and are involved in the pathogenesis of AD. The mechanism of ERS plus the modulation of AßPP processing and GSK3ß activity by ERS in AD are summarized and explored in this review.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Estrés del Retículo Endoplásmico/fisiología , Glucógeno Sintasa Quinasa 3 beta/metabolismo , Animales , Humanos
4.
Cell Mol Immunol ; 2(1): 63-7, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16212913

RESUMEN

Activin A is a kind of pre-inflammatory factor that belongs to the transforming growth factor-beta (TGF-beta) superfamily. To investigate the effect and mechanism of activin A on the activities of mouse macrophages, the secretion of NO in the supernatant of cultured mouse peritoneal macrophages was examined by NO assay kit, and the expression of iNOS, ActRIIA and ARIP2 mRNA in mouse peritoneal macrophages was analyzed by RT-PCR. The results showed that activin A stimulated the secretion of NO and the expression of iNOS mRNA in non-activated mouse macrophages in a time- and dose-dependent manner. In contrast, activin A in the same concentration inhibited the secretion of NO in LPS-activated mouse macrophages in a dose-dependent manner. ActRIIA was highly expressed on macrophages, and activin A upregulated the ActRIIA mRNA expression in macrophages. Anti-ActRIIA antibody can block the secretion of NO from the macrophages stimulated by activin A. Furthermore, RT-PCR analysis revealed that activin A enhanced the ARIP2 mRNA expression in macrophages. These results indicated that Activin A may be a weak activator compared with LPS to mouse macrophages, and activin A may modulate the secretion of NO through ActRIIA-ARIP2 signal pathway in mouse macrophages.


Asunto(s)
Activinas/farmacología , Subunidades beta de Inhibinas/farmacología , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/fisiología , Receptores de Activinas Tipo II/genética , Receptores de Activinas Tipo II/metabolismo , Proteínas Adaptadoras Transductoras de Señales/genética , Animales , Células Cultivadas , Femenino , Regulación de la Expresión Génica/genética , Lipopolisacáridos/farmacología , Macrófagos Peritoneales/metabolismo , Proteínas de la Membrana/genética , Ratones , Ratones Endogámicos C57BL , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/genética , ARN Mensajero/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...